JINAL PATEL: Open Payments
NPI 1043944002 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 45 payments from 17 companies in 2025. Trend: 2023 $1,029 · 2024 $1,038 · 2025 $1,277
Food & beverage: $1,277
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $293 |
| Lilly USA, LLC | 7 | $220 |
| PolyNovo North America LLC | 6 | $141 |
| AngioDynamics, Inc. | 2 | $115 |
| Astellas Pharma US Inc | 1 | $109 |
| GlaxoSmithKline, LLC. | 4 | $81 |
| Novo Nordisk Inc | 2 | $53 |
| PFIZER INC. | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $34 |
Products named: MOUNJARO, NOVOSORB BTM, AIRSUPRA, AURYON LASER SYSTEM 100-120 VAC, Cresemba, JARDIANCE, BREZTRI, SHINGRIX.
Industry payments across CA — which companies pay providers there.
